TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 8,345 followers.

TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation https://t.co/meqx2OMg7z

26 Jun 2023

Reply Repost Favourite

RT @JournalofExper1: Published!✅ TRPM7 silencing modulates 𝐠𝐥𝐮𝐜𝐨𝐬𝐞 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐫𝐞𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐢𝐧𝐠 to inhibit the growth of #𝐨𝐯𝐚𝐫𝐢𝐚𝐧𝐜𝐚𝐧𝐜𝐞𝐫 by enha…

10 Feb 2022

Reply Repost Favourite

10 Feb 2022

Reply Repost Favourite

TRPM7 silencing modulates 𝐠𝐥𝐮𝐜𝐨𝐬𝐞 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐫𝐞𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐢𝐧𝐠 to inhibit the growth of #𝐨𝐯𝐚𝐫𝐢𝐚𝐧𝐜𝐚𝐧𝐜𝐞𝐫 by enhancing AMPK activation to promote HIF-1α degradation

10 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.